University of Cincinnati: Combination Immunotherapy Helps Overcome Melanoma Treatment Resistance
November 08, 2025
November 08, 2025
CINCINNATI, Ohio, Nov. 8 -- The University of Cincinnati issued the following news:
* * *
Combination immunotherapy helps overcome melanoma treatment resistance
Cancer Center researcher presents abstract at SITC Annual Meeting
By Tim Tedeschi, 513-556-5694, tedesctd@ucmail.uc.edu
Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment . . .
* * *
Combination immunotherapy helps overcome melanoma treatment resistance
Cancer Center researcher presents abstract at SITC Annual Meeting
By Tim Tedeschi, 513-556-5694, tedesctd@ucmail.uc.edu
Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment . . .
